Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.

Zarrabi, Kevin K; Handorf, Elizabeth; Miron, Benjamin; Zibelman, Matthew R; Anari, Fern; Ghatalia, Pooja; Plimack, Elizabeth R; Geynisman, Daniel M

Zarrabi, Kevin K; Handorf, Elizabeth; Miron, Benjamin; Zibelman, Matthew R; Anari, Fern; Ghatalia, Pooja; Plimack, Elizabeth R; Geynisman, Daniel M.

Afiliação

Zarrabi KK; Department of Medical Oncology, Sidney Kimmel Cancer Center-Thomas Jefferson University, Philadelphia, PA, USA.
Handorf E; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.
Miron B; Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.
Zibelman MR; Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.
Anari F; Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.
Ghatalia P; Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.
Plimack ER; Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.
Geynisman DM; Department of Hematology/Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA.

Oncologist ; 28(2): 157-164, 2023 02 08.

Article em En | MEDLINE | ID: mdl-36200791

Assuntos

Carcinoma de Células Renais; Neoplasias Renais; Humanos; Nivolumabe/farmacologia; Nivolumabe/uso terapêutico; Ipilimumab/farmacologia; Ipilimumab/uso terapêutico; Carcinoma de Células Renais/tratamento farmacológico; Carcinoma de Células Renais/patologia; Axitinibe/farmacologia; Axitinibe/uso terapêutico; Estudos Retrospectivos; Estudos Prospectivos; Neoplasias Renais/tratamento farmacológico; Neoplasias Renais/patologia; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico

Palavras-chave

immunotherapy; metastatic renal cell carcinoma; real-world outcomes; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google